Search

everythinglearnresearchcommunity

for

Search:↓

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

Certain drugs that block specific enzymes can help treat prostate diseases.

Glioblastoma cells can make androgens, which might help the tumor grow.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Putting ketoconazole on the skin can help mice grow hair.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

The document concludes that Catalyst software is effective for drug design, identifying potent compounds for various medical conditions.

Gene mutations can cause problems in male genital development.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Certain hormone levels can help diagnose P450 oxidoreductase deficiency.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Drugs for hormone-related conditions might help treat mental disorders but could have serious side effects.

Finasteride exposure in pregnancy causes genital abnormalities in male rats.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Ketoconazole cream is effective for skin conditions like seborrheic dermatitis and may help with hair loss and other skin issues, with generally mild side effects.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.